Paul Kang
Chief Executive Officer bei EXICURE, INC.
Ursprung des Netzwerks ersten Grades von Paul Kang
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 17 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Paul Kang
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Investor Relations Contact | |
| BEAM SUNTORY INC | Beverages: Alcoholic | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Public Communications Contact | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Public Communications Contact | |
| MOLOGEN AG | Miscellaneous Commercial Services | Chief Executive Officer | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree | |
| East Carolina University | College/University | Graduate Degree | |
| Emerson College | College/University | Graduate Degree | |
| University of London | College/University | Doctorate Degree | |
| The King's College (New York) | College/University | Undergraduate Degree | |
| University of Illinois | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree | |
| CBI CO., LTD. | Auto Parts: OEM | Director/Board Member | |
| JOKWANG ILI CO., LTD. | Industrial Machinery | Comptroller/Controller/Auditor | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Wright State University (Ohio) | College/University | Graduate Degree | |
Kent County Memorial Hospital
 Kent County Memorial Hospital Hospital/Nursing ManagementHealth Services Kent County Memorial Hospital provides health care services. It also provides inpatient services including cardiology and extended coronary care, infectious disease, primary care, oncology, orthopedics, obstetrics and gynecology, pediatrics, rehabilitation and surgery. The company was founded in 1951 and is headquartered in Warwick, RI. | Hospital/Nursing Management | Corporate Officer/Principal | |
| University of Hannover | College/University | Undergraduate Degree | |
| Freie Universität Berlin | College/University | Doctorate Degree | |
Shinhan Venture Investment Co. Ltd.
 Shinhan Venture Investment Co. Ltd. Investment ManagersFinance Shinhan Venture Investment Co. Ltd. (Shinhan Venture Investment) is a Private Equity/Venture Capital firm, a subsidiary of Shinhan Venture Investment founded in 2000. The firm headquartered in Seoul. | Investment Managers | Private Equity Investor | |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
St. Thomas Hospital, Inc.
 St. Thomas Hospital, Inc. Hospital/Nursing ManagementHealth Services St. Thomas Hospital, Inc. operates hospitals. The private company is based in St. Thomas, VI. and has subsidiaries in United States. | Hospital/Nursing Management | Corporate Officer/Principal | |
| SIGNAL INFORMATION & COMMUNICATION CORP | Information Technology Services | Chief Executive Officer | |
Verband Forschender Arzneimittelhersteller eV
 Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Miscellaneous Commercial Services | Director/Board Member | |
| US Air Force | Sovereign | Consultant / Advisor | |
| Pohang University | College/University | Undergraduate Degree | |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Chief Operating Officer | |
| HUM&C CO., LTD. | Household/Personal Care | Director/Board Member | |
| ALECTOR, INC. | Biotechnology | Director/Board Member | |
| Tufts University School of Medicine | College/University | Graduate Degree | |
| Brody School of Medicine | College/University | Doctorate Degree | |
| Graduate School of Environmental Studies Seoul Natl University | College/University | Undergraduate Degree | |
Claris Ventures Sgr SpA
 Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | Investment Managers | Private Equity Investor | |
Adjuvant Capital LP
 Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Pharmaceuticals: Major | Consultant / Advisor | |
Inceptor Bio LLC
 Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | Biotechnology | Chief Executive Officer | |
| Institute For Advanced Clinical Trials For Children | Director/Board Member | ||
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Consultant / Advisor | |
Resalis Therapeutics SRL
 Resalis Therapeutics SRL Miscellaneous Commercial ServicesCommercial Services Resalis Therapeutics SRL is a company that focuses on developing a transformative metabolic disease approach to target obesity and fatty liver disease. The company is based in Turin, Italy. The Italian company's lead program, RES-010, is a safe and convenient treatment that provides disease-modifying therapeutic impact, including durable weight loss and reduction of hepatic steatosis. The CEO of the company is Eva Castagnetti. | Miscellaneous Commercial Services | Director/Board Member | |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chief Executive Officer | |
| ALKERMES PLC | Pharmaceuticals: Major | Public Communications Contact |
Statistik
International
| Vereinigte Staaten | 29 |
| Südkorea | 8 |
| Deutschland | 5 |
| Schweiz | 3 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 18 |
| Consumer Services | 15 |
| Commercial Services | 6 |
| Finance | 4 |
| Consumer Non-Durables | 3 |
Operativ
| Director/Board Member | 23 |
| Corporate Officer/Principal | 12 |
| Undergraduate Degree | 10 |
| Independent Dir/Board Member | 8 |
| Chief Executive Officer | 7 |
